W

ASHINGTON — It’s the literary equivalent of a campaign contribution: a well-placed op-ed piece, endorsing an agency nominee awaiting Senate confirmation. It’s How Washington Works. But few contenders have racked up the sheer number of public tributes as Scott Gottlieb, President Trump’s choice for FDA commissioner, who was confirmed by a Senate vote Tuesday.

Drug company lobbyists, academics with health industry funding, and a flurry of former colleagues have all picked up their pens on behalf of Gottlieb, the 44-year-old physician and former FDA deputy commissioner.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.